Drugs to cost just 20-30 per cent of price at Jan Aushadhi stores
The generic drugs that would be made available at ‘Jan Aushadhi’ stores across the country would be made available at 20-30 per…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Happy of government’s proactive support: GVK BIO CEO
Commerce Secy may take the GVK BIO case to WTO
IPGA, RDCA organise public awareness programme
More than 250 retailers and distributors of NCT Delhi were invited to participate in the session
US FDA, DCG(I) explore more ways to work together
Willing to collaborate with Indian regulators, other stakeholders: US FDA
SC stays Delhi HC order against Glenmark
Company can make, sell its brands of MSD's diabetes products till April 28
End of Wockhardt’s Chikalthana USFDA woes?
No major findings from recent USFDA inspection, after 2013 import alert on the company's Aurangabad-based Waluj and Chikalthana…
Sun Pharma closes merger deal with Ranbaxy
The combined entity’s manufacturing footprint covers five continents with products sold in over 150 nations
Biotech start ups get govt-backed equity fund
The BIRAC AcE Fund aims to accelerate growth of biotech startups
Jan Aushadhi scheme to be revamped
Faced with the under-performance of the Jan Aushadhi scheme, the government has decided to revamp the scheme